- Home
- GROW vs CALC Comparison
GROW vs CALC Comparison
Compare GROW & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- CALC
- Stock Information
- Founded
- GROW 1968
- CALC 2011
- Country
- GROW United States
- CALC United States
- Employees
- GROW N/A
- CALC N/A
- Industry
- GROW Investment Managers
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- GROW Finance
- CALC Health Care
- Exchange
- GROW Nasdaq
- CALC Nasdaq
- Market Cap
- GROW 32.9M
- CALC 36.0M
- IPO Year
- GROW N/A
- CALC N/A
- Fundamental
- Price
- GROW $2.23
- CALC $1.90
- Analyst Decision
- GROW
- CALC Strong Buy
- Analyst Count
- GROW 0
- CALC 4
- Target Price
- GROW N/A
- CALC $17.25
- AVG Volume (30 Days)
- GROW 26.7K
- CALC 32.8K
- Earning Date
- GROW 05-08-2025
- CALC 03-27-2025
- Dividend Yield
- GROW 4.02%
- CALC N/A
- EPS Growth
- GROW N/A
- CALC N/A
- EPS
- GROW 0.04
- CALC N/A
- Revenue
- GROW $9,421,000.00
- CALC N/A
- Revenue This Year
- GROW N/A
- CALC N/A
- Revenue Next Year
- GROW N/A
- CALC N/A
- P/E Ratio
- GROW $60.71
- CALC N/A
- Revenue Growth
- GROW N/A
- CALC N/A
- 52 Week Low
- GROW $2.21
- CALC $1.83
- 52 Week High
- GROW $2.95
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- GROW 16.73
- CALC 29.68
- Support Level
- GROW $2.27
- CALC $2.02
- Resistance Level
- GROW $2.35
- CALC $2.28
- Average True Range (ATR)
- GROW 0.04
- CALC 0.23
- MACD
- GROW -0.02
- CALC -0.02
- Stochastic Oscillator
- GROW 5.85
- CALC 10.94
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.